Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Boyle MD, Brady LJ. Novel bacterial markers for pathogenic group B streptococci. US Patent 5,098,827 dated Mar 24 1992
Boyle MD, Brady LJ. Gamma antigen of pathogenic group B streptococci. US Patent 5,721,339 dated Feb 24 1998
Boyle MD, Brady LJ. Antigen of group B streptococci. US Patent 5,472,696 dated Dec 5 1995
